XTINBEQ
DEAD

Serial Number

88920734

Owner

Celgene Corporation

Attorney

Marilyn F. Kelly

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

XTINBEQ Trademark

Serial Number: 88920734

XTINBEQ is a trademark filed by Celgene Corporation on May 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 18, 2020

Registration Date

Not Registered

Published for Opposition

March 23, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 12, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 24, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2023 EXRA
SOU EXTENSION 5 GRANTED
Nov 8, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 8, 2023 AITU
SOU EXTENSION 5 FILED
Nov 3, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 3, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2023 EXRA
SOU EXTENSION 4 GRANTED
Apr 28, 2023 EX4G
SOU EXTENSION 4 FILED
Apr 28, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2022 EXRA
SOU EXTENSION 3 GRANTED
Nov 9, 2022 EX3G
SOU EXTENSION 3 FILED
Nov 9, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 9, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2022 EXRA
SOU EXTENSION 2 GRANTED
May 9, 2022 EX2G
SOU EXTENSION 2 FILED
May 9, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
May 9, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 20, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 20, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 20, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 18, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 19, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 19, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 19, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP